EvoPair™ is a non-medical, privacy-first platform for intentional parenthood, enabling individuals to assess reproductive compatibility using consumer genetic data, personal values, and declared reproductive intent — before conception and without romantic matching.
EvoPair builds the missing pre-clinical layer in reproductive decision-making.
We reduce genetic and social risks before people enter clinics, contracts or treatments.
This makes reproduction safer, cheaper and more intentional — without becoming a medical product.
This platform is designed as a non-medical, decision-support system. It does not diagnose, treat, prevent, or manage any medical conditions.
The system processes user-provided consumer genetic data solely to generate compatibility indicators for personal planning and matching purposes. No clinical recommendations, medical interpretations, or therapeutic guidance are provided. The platform does not operate as a laboratory, medical device, or healthcare service provider. As a result, it operates outside the scope of FDA medical device regulation.
EvoPair™ employs a "Processing-only" model for all genomic information to ensure maximum user security. Upon the upload of raw DNA data, the system extracts specific markers required for the Compatibility Score. Following this extraction:
Automatic Deletion: The original raw data file is permanently purged from our production servers immediately after processing.
Metadata Storage: Only the resulting compatibility indices (non-identifiable mathematical values) are retained to facilitate the matching process.
No Third-Party Sharing: EvoPair™ does not sell, lease, or share genetic raw data with third-party advertisers or pharmaceutical companies by design.
EvoPair™ operates under the principle of Privacy by Design. Our infrastructure is engineered to prioritize data sovereignty, ensuring that complex genetic and personal analysis never compromises individual anonymity.
1. DNA Data Processing (Non-Storage Policy)
EvoPair™ is a decision-support platform, not a biobank or a genetic laboratory. We act as a "secure transient processor":
• Raw Data Processing: Users upload raw DNA files (TXT/CSV formats) from recognized providers such as 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA.
• Instant De-identification: Once the specific markers required for compatibility analysis (SNP genotyping for CFTR, SMN1, HBB, metabolic risks, and immunological markers) are extracted, the original raw file is permanently deleted from our servers.
• Encryption Standards: All intermediate computations are secured using AES-256 industrial-grade encryption.
2. User Anonymity & Identification Control
To eliminate bias and prevent unauthorized data disclosure, our system follows strict identification protocols:
• ID-Based Profiles: Every user is assigned a unique alphanumeric ID. Legal names are never disclosed to other participants until a mutual match is confirmed.
• Financial Data Masking: Income verification (Tax Returns) is used solely for internal validation and "Compatibility Score" calculation. To prevent socio-economic discrimination, specific income figures are hidden from public profiles.
• Double Opt-in Disclosure: Contact information is only exchanged after both parties have explicitly granted permission following a successful match.
3. Ethical Protocol & Regulatory Compliance
Our governance framework is built to align with global data protection standards:
• Zero-Knowledge Architecture: Our system is designed so that even EvoPair™ administrators cannot link a specific genetic profile back to a real-world identity once the initial processing is complete.
• Consent Management: Users maintain 100% control over which datasets (Lifestyle, Values, Geography) are active within the matching algorithm at any given time.
• Scalable Compliance: Our protocols are structured to meet the rigorous demands of GDPR (Europe) and CCPA (USA) regarding the handling of sensitive biometric and personal information.
Why This Matters for Investors
• Risk Mitigation: By implementing a Non-storage policy, we significantly reduce the legal and financial liabilities associated with data breaches.
• Business Model Integrity: We provide "Information Support" rather than "Medical Diagnostics," positioning EvoPair™ as a scalable tech platform rather than a regulated medical entity.
• Trust & Retention: In the era of data commercialization, our commitment to deleting raw DNA files is a powerful competitive advantage that drives user trust and high-quality lead generation.
Choose your side
EvoPair™ is currently open for Pre-Seed discussions with visionary partners and institutional investors.
EvoPair™ | Patent Pending
Copyright © 2026 EvoPair. All rights reserved.
Reproductive Intent Infrastructure is a proprietary research framework. The methodology and pilot design are subject to pending patent applications.
AI-assisted Compatibility Research